Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Monika Fischer"'
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Autor:
Andres Yarur, Freddy Caldera, Sirimon O'Charoen, Joshua R. Korzenik, Cecile Norris, Matthew Bohm, Monika Fischer, Sara Sweeney, Alandra Weaver, Uni Wong, Sushila Dalal, Themistocles Dassopoulos, Katerina Wells, David Hudesman, Lilani P. Perera, Shrinivas Bishu, Caren Heller, Richard H. Duerr, Tara Fehlmann, Deepak Parakkal, Raymond K. Cross, James D. Lewis, Manreet Kaur, Matthew A. Ciorba, Sumona Saha, Elizabeth A. Scoville, Laura E. Raffals, Joel Pekow, Scott B. Snapper, Angela Dobes, Meenakshi Bewtra
Publikováno v:
Inflamm Bowel Dis
Background Clinical and molecular subcategories of inflammatory bowel disease (IBD) are needed to discover mechanisms of disease and predictors of response and disease relapse. We aimed to develop a study of a prospective adult research cohort with I
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Gastroenterology Clinics of North America. 49:739-752
"Patients with inflammatory bowel disease, including ulcerative colitis (UC) and Crohn disease, have altered gut microbiomes. The success of fecal microbiota transplantation (FMT) in the treatment of Clostridioides difficile infection, a disease that
Publikováno v:
Gastroenterology. 160:1483-1485
Autor:
Monika Fischer, Yao-Wen Cheng
Publikováno v:
Current Treatment Options in Gastroenterology. 17:524-533
Purpose of review This article will review current management strategies for severe and fulminant Clostridioides difficile infection (CDI). Recent findings Clostridioides difficile is the most common nosocomial cause of infectious diarrhea. With the
Autor:
Colleen R. Kelly, Benjamin H. Mullish, Ari Grinspan, Monika Fischer, Jessica R. Allegretti, Zain Kassam
Publikováno v:
Gastroenterology. 159:1982-1984
There has been an increase in the burden of Clostridioides difficile infection (CDI),1 especially in high-risk populations such as patients with inflammatory bowel disease (IBD).2 The prevalence of CDI in the IBD population is up to 8-fold higher tha
Autor:
Bruce E. Sands, Robert Hirten, Keith Sultan, David Faleck, Jenna L. Koliani-Pace, Shannon Chang, Michelle Luo, Eugenia Shmidt, David Hudesman, William J. Sandborn, Youran Gao, Parambir S. Dulai, Bo Shen, Monika Fischer, Preeti Shashi, Dana J. Lukin, A Weiss, Sunanda V. Kane, Gursimran Kochhar, Jiao Yang, Arun Swaminath, Joseph Meserve, Satimai Aniwan, Edward V. Loftus, Siddharth Singh, Adam Winters, Matthew Bohm, Shreya Chablaney, Zhongwen Huang, Sashidhar Varma, Nitin Gupta, Brigid S. Boland, Karen Lasch, Jean-Frederic Colombel, Corey A. Siegel
Publikováno v:
Inflammatory Bowel Diseases
Background Vedolizumab effectiveness estimates immediately after Food and Drug Administration (FDA) approval for ulcerative colitis (UC) and Crohn’s disease (CD) are limited by use in refractory populations. We aimed to compare treatment patterns a
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:345-352
Clostridium difficile infection (CDI) has become the leading cause of nosocomial infection in the United States with significant risk of both morbidity and mortality. While antimicrobial therapy forms the basis of treatment, there are several clinica
Autor:
Ellen Scherl, Angela Dobes, Monika Fischer, Meenakshi Bewtra, Arun Swaminath, Jeffrey R. Curtis, Charlene Compher, Lindsey Albenberg, James D. Lewis, Kyle Bittinger, Ann D. Flynn, Michael D. Kappelman, Benjamin L Cohen, Andrea Meyer, Akriti Saxena, Kimberly Braly, Sara N. Horst, Robert S. Sandler, Sumona Saha, Lisa Nessel, David L. Suskind, John S. Hanson, Bruce R. Yacyshyn, Colleen M. Brensinger, Scott G. Daniel, Liam McKeever, Hongzhe Li, Hans H Herfarth, Maureen McCauley, John F. Valentine, Carol Brotherton
Publikováno v:
Gastroenterology. 161(3)
Background & Aims This study compared the effectiveness of the Specific Carbohydrate Diet (SCD) to the Mediterranean diet (MD) as treatment for Crohn's disease (CD) with mild to moderate symptoms. Methods Adult patients with CD and with mild-to-moder
Autor:
Benjamin H. Mullish, Monika Fischer, Jonathan Hurtado, Sashidhar Sagi, Zain Kassam, Colleen R. Kelly, Sara Nemes, Ari Grinspan, Michael Silverstein, Matthew Bohm, Will Pettee, James L. Alexander, Madeline Carrellas, Jesus Miguens Blanco, Julian Marchesi, Alexandros Pechlivanis, Emmalee Phelps, Jenna Marcus, Julie A. K. McDonald, Ylaine Gerardin, Kate Gallagher, Jessica R. Allegretti, Grace F. Barker
Publikováno v:
Inflamm Bowel Dis
Background Recurrent Clostridioides difficile infection (CDI) in patients with inflammatory bowel disease (IBD) is a clinical challenge. Fecal microbiota transplantation (FMT) has emerged as a recurrent CDI therapy. Anecdotal concerns exist regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981de99c3ecbbf74c12b5d4d21b359c7
http://hdl.handle.net/10044/1/84552
http://hdl.handle.net/10044/1/84552